Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Financial News

Oct. 16 Financial Quick Takes: Hong Kong IPO could value Ascentage at $876M; plus Principia, Rhythm, ProQR, dMed, Ionova and Amarna

October 17, 2019 12:28 AM UTC
Updated on Oct 17, 2019 at 12:32 AM UTC

Ascentage sets Hong Kong IPO terms
Ascentage Pharma Group International would raise HK$404.4 million ($51.6 million) and be valued at HK$6.9 billion ($876.4 million) if it prices its Hong Kong IPO at the mid-point of its proposed range. Ascentage proposed to sell 12.2 million shares at $HK32.20-HK$34.20. The company refiled to list in April after letting its application lapse.

Principia, Rhythm, ProQR price follow-ons
At least three companies raised follow-ons Wednesday, with Principia BioPharma Inc. (NASDAQ:PRNB) raising the most at $210 million in a bumped-up offering. The company sold 7.5 million shares at $28, a 6% discount from Tuesday’s close of $29.91. The company had proposed to raise $125 million. Rhythm Pharmceuticals Inc. (NASDAQ:RYTM) raised $150 million in its offering of 8.1 million shares at $18.50, an 11% discount from Tuesday’s close of $20.89. ProQR Therapeutics N.V. (NASDAQ:PRQR) raised $50 million via the sale of 9.1 million shares at $5.50 a share, a 12% discount from Tuesday’s close of $6.22...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article